Dr. Al Jazayrly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1300 n. Vermont Ave
Ste. 606
Los Angeles, CA 90027Phone+1 323-660-6200Fax+1 323-660-6212- Is this information wrong?
Summary
- Dr. Ghassan Al Jazayrly is an oncologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Hollywood Presbyterian Medical Center, Glendale Memorial Hospital and Health Center, Adventist Health Glendale, and USC Verdugo Hills Hospital. He received his medical degree from University of Aleppo Faculty of Medicine and has been in practice 32 years. He also speaks multiple languages, including Arabic and Spanish. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
- University of California Davis HealthFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1992 - 1995
- University of California (San Francisco)/FresnoInternship, Internal Medicine, 1991 - 1992
- University of Aleppo Faculty of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1993 - 2025
Clinical Trials
- Neuropathic Pain in Patients With Cancer Start of enrollment: 2006 Jun 01
- Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia Start of enrollment: 2007 Aug 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Join now to see all
Publications & Presentations
PubMed
- The price of remission.Al-Jazayrly, G., Lau, D. H.> ;West J Med. 1997 Mar
- Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.Lim, N., Lara, P. N., Lau, D. H., Edelman, M. J., Tanaka, M., al-Jazayrly, G., Houston, J., Lauder, I., Gandara, D. R.> ;Cancer Invest. 2003
Research History
- Principle Investigator at California Research InstitutePrinciple Investigator at California Research Institute2019 - Present
Professional Memberships
- Member
- Member
- Member
- European society of medical oncologyMember
Other Languages
- Arabic, Spanish, Filipino, Armenian, Russian
Hospital Affiliations
- CHA Hollywood Presbyterian Medical CenterLos Angeles, California
- Glendale Memorial Hospital and Health CenterGlendale, California
- Adventist Health GlendaleGlendale, California
- USC Verdugo Hills HospitalGlendale, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: